4.6 Article

Choice of Initial Antiepileptic Drug for Older Veterans: Possible Pharmacokinetic Drug Interactions with Existing Medications

Journal

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
Volume 58, Issue 3, Pages 465-471

Publisher

WILEY
DOI: 10.1111/j.1532-5415.2010.02732.x

Keywords

drug-drug interaction; epilepsy; geriatrics; antiepileptic drugs

Funding

  1. Department of Veterans Affairs, Health Services Research and Development Service [IIR-02-274]
  2. Epilepsy Foundation
  3. VA Health Services Research and Development Service (HSRD) [MRP-05-145]
  4. VA HSR& D Career Development Transition Award [01-013]
  5. National Institute on Aging Paul Beeson Career Development Award [1K23AG030999]
  6. South Texas Veterans Healthcare System/Audie L. Murphy Division
  7. VERDICT research program

Ask authors/readers for more resources

OBJECTIVES To identify clinically meaningful potential drug-drug interactions (PDIs) with antiepileptic drugs (AEDs), the AEDs and co-administered drugs commonly associated with AED-PDIs, and characteristics of patients with high likelihood of AED-PDI exposure. DESIGN Five-year retrospective cohort study of veterans with new-onset epilepsy. SETTING National Veterans Affairs and Medicare databases. PARTICIPANTS Veterans aged 66 and older with a new diagnosis of epilepsy between October 1, 1999, and September 30, 2004 (N=9,682). MEASUREMENTS AED-PDI was restricted to clinically meaningful PDIs identified using prior literature review. AED-PDIs were identified using participants' date of initial AED prescription and overlapping concomitant medications. Logistic regression analysis identified factors associated with AED-PDI, including demographic characteristics, chronic disease states, and diagnostic setting. RESULTS AED-PDI exposure was found in 45.5% (4,406/9,682); phenytoin, a drug with many PDIs, was the most commonly prescribed AED. Cardiovascular drugs, lipid-lowering medications, and psychotropic agents were the most commonly co-administered AED-PDI medications. Individuals with AED-PDI exposure were more likely to have hypertension (odds ratio (OR)=1.46, 99% confidence interval (CI)=1.24-1.82) and hypercholesterolemia (OR=1.40, 99% CI=1.24-1.57) than those without and to be diagnosed in an emergency or primary care setting than a neurology setting (emergency: OR=1.30, 99% CI=1.08-1.58; primary care: OR=1.29 99% CI=1.12-1.49). CONCLUSION Exposure to AED-PDI was substantial but less common in patients with epilepsy diagnosed in a neurology setting. Because potential outcomes associated with AED-PDI include stroke and myocardial infarction in a population already at high risk, clinicians should closely monitor blood pressure, coagulation, and lipid measures to minimize adverse effects of AED-PDIs. Interventions to reduce AED-PDIs may improve patient outcomes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available